Berkshire buys Teva, bites more Apple, feels IBM blues

FILE PHOTO: Berkshire Hathaway shareholders walking by a video screen at the company's annual meeting in Omaha
FILE PHOTO: Berkshire Hathaway shareholders walk by a video screen at the company’s annual meeting in Omaha, Nebraska, U.S., May 4, 2013. REUTERS/Rick Wilking/File Photo

February 14, 2018

(Reuters) – Warren Buffett’s Berkshire Hathaway Inc <BRKa.N> on Wednesday said it has taken a new stake in Teva Pharmaceutical Industries Ltd <TEVA.TA>, significantly boosted its holdings of Apple Inc <AAPL.O> and has nearly shed a less successful investment in IBM Corp <IBM.N>.

In a regulatory filing detailing its U.S.-listed stock holdings as of Dec. 31, Berkshire reported owning about 18.9 million of the American depositary receipts in Teva, one of the world’s largest generic drug makers, worth about $358 million.

Teva’s share price rose more than 10 percent after Berkshire reported its ownership stake.

Berkshire also reported a 23 percent increase since the end of September in its Apple stake, to about 165.3 million shares, and a 94.5 percent decline in its stake in International Business Machines Corp, to 2.05 million shares.

(Reporting by Jonathan Stempel in New York; Editing by Leslie Adler)

Free America Network Articles

Leave a Comment